Abstract: This work presents a novel HIV epidemic model where the infected population is described by a continuous-distributed system with an infection progression coordinate. This coordinate can represent heterogeneities of the infected population which results in a more suitable HIV characterization than the one used in multi-compartmental models. Transition rates and treatment parameters commonly defined for compartmental models are replaced by a diffusion term based on the progression coordinate. The diffusion coefficient is a function of the disease treatment strategies that affect the infection progression rate. The resulting PDE that describes the infected class dynamics is solved with standard numerical techniques. The proposed model is used to evaluate potential treatment strategies for HIV and can be extended to other infectious diseases without major modifications.
INTRODUCTION
Mathematical Models have been used to predict HIV epidemic dynamics from the early stage of the infection to its endemic equilibrium state [Chen, 2006] [Grenfell et al., 2004] . Examples of applications of models for HIV dynamics include, but are not limited to, determining the cost benefit of vaccination programs [Edwards et al., 1998 ], estimating epidemic parameters [Cazelles and Chau, 1997] , and evaluating the migration impact on the HIV spread [Coffee et al., 2007] .
Models for HIV dynamics usually divide the population into three different groups: (1) susceptible individuals who do not carry HIV but have the risk to be infected, (2) infected individuals who are HIV positive, but have not developed AIDS symptoms, and (3) individuals who have developed symptoms related to AIDS. In HIV epidemic modeling the susceptible individuals as well as the population that has developed AIDS are lumped into separate homogeneous groups. However, the infected class is often divided into several subgroups or compartments based upon the progression of the infection. HIV multicompartment models account for the wide variety of viral levels in infected individuals [Hyman et al., 1999] [Hyman et al., 2001] . The fact that two HIV infected individuals rarely share identical conditions indicates that this disease progresses through many stages, which also needs to be reflected in mathematical models [Wearing et al., 2005] . This heterogeneity of the infected class can be used to determine optimal treatment based on the different infection stages. Finally, medication often delays the progression of HIV, eliminates several symptoms and improves patients' quality of life [Cai et al., 2009] . These treatment benefits are not properly accounted for in models where only a limited number of compartments are used to describe the infected class.
An alternative to describing the infected class as a series of predefined compartments is to treat as a continuous population. Partial Differential Equations (PDE) [Keeling and Rohani, 2008] naturally arise when describing continuous class models. Continuous space models have been used to describe the spread of an infectious disease in a region [Murray, 2003] and to understand the infection spread [Reluga, 2004] . These PDE models include a diffusion term to represent the free movement of infected individuals in an environment [Coffee et al., 2007] . In contrast to the study of infection migration, the diffusion term considered in this paper accounts for the disease progression as well as treatment. This diffusion term determines the disease progression from the initial moment of the infection to the time AIDS symptoms started to develop. A diffusion coefficient is defined to adjust the disease progression rate. Medication diminishes this coefficient when treatment is initiated, which will eventually slows the disease progression. Slow disease progression increases the probability of natural mortality in the infected class population. The proposed model also permits one to simulate variants in HIV treatment without requiring a predefined number of infected class compartments. This paper is organized as follows: Section 2 describes the HIV model classes and the assumptions considered in this research work. The mathematical formulation, comparison with existing models and the endemic equilibrium profiles are provided as part of the model description. The epidemic dynamic response is discussed in Section 3, where treatment is initiated at different stages of the infection. The results show that the diffusion term used in the proposed approach can account for the progression and treatment of HIV. The importance of early treatment is quantified by the natural mortality proportion increase in the infected population. Conclusions are provided in Section 4. represents the natural mortality constant, d is the AIDS mortality constant and η is the infection progression coordinate. β I and k I are the disease transmission and AIDS relocation constants, respectively.
MODEL DEVELOPMENT AND CHARACTERISTICS
The development of the HIV epidemic model divides the total population into three main classes. These are:
• Susceptible, S; represents individuals susceptible to HIV infection by either contaminated blood products, sexual intercourse or mother to child transmission.
• Infected, I; represents the group which is HIV positive, and includes asymptomatic as well as symptomatic hosts. Inside the infected class the progression of the disease ranges from individuals who just contracted the virus, to the ones who are about to experience symptoms resulting from AIDS.
• AIDS, A; the AIDS class represents individuals that have gone through the different infection stages and are now removed from the active population. The death rate for this class is greater than for S and I.
This work defines homogeneous compartments for the susceptible as well as for AIDS classes because there is no major illness differentiation for the individuals in each of these groups. In contrast to this, the infected class is considered heterogeneous because the infection can have an infinite number of stages. Figure 1 is a diagram of the Susceptible, Infected and AIDS model, in short SIA. This model structure is similar to the SIR model [Dietz, 1976] with the exception that individuals do not recover but instead acquire AIDS. The S and A classes are represented by homogeneous compartments attached to the start and end of the infected class, respectively. The middle block denotes the infected population distributed along the disease progression coordinate, η. The population flux goes from left to right, following the SIA sequence. A diffusion mechanism defines the progression of the disease inside I, where a diffusion coefficient determines how fast the disease progresses. The non-disease mortality parameter µ is distributed along all three classes as shown in the figure.
Mathematical Formulation
The susceptible population dynamics in the absence of infected individuals is given by,
where µ represents the natural mortality constant and K is the number of susceptible individuals at equilibrium conditions. In the presence of the infected class the number of susceptible individuals at equilibrium drops below K, and the dynamics of the susceptible population becomes,
where β S represents the disease transmission constant for the susceptible class, andÎ is a representative average of the infected class,Î
The infection progression coordinate and the transmission weight are represented by η ∈ [0 1] and w, respectively. Some researchers make use of different transmission rates for each compartment in the infected class [Hyman and Li, 2005] , which suggests that β i (η) ≡ w(η i )β S . Nevertheless, it has been shown that the infection progression stage η does not affect the disease transmission risk [Bachar and Dorfmayr, 2004] , which indicates that w(η) = 1 is a reasonable assumption.
The infected population dynamics is defined by the follow-
where D is the disease progression coefficient and depends on the progression coordinate, η. D is also referred to as the diffusion coefficient because it regulates the progression of the disease by adjusting a diffusion mechanism term. Symptomatic infected individuals who receive medication tend to have a slower infection progression than asymptomatic individuals. This behavior follows the pattern of most patients in which no major medication action is taken until the presence and symptoms of the disease are manifested.
It is assumed that the first infected individuals are at the initial stage of the disease, i.e I(η, 0) = 0 for η = 0 and I(0, 0) = I 0 . Boundary conditions are given by:
• The flux into the infected population, given by susceptible individuals that become infected,
where the parameter β I determines the transmission of the disease.
• The flux out of the infected population, which represents individuals that are about to develop AIDS,
where k I is the transfer rate constant to the AIDS class.
The shape of the diffusion coefficient profile for 0 ≤ η ≤ 1 depends on the infection progression stage at which medication is expected to be supplied, η m . Figure 2 illustrates a typical profile for the diffusion coefficient used for the infected class. A significant drop in the diffusion coefficient is expected for η > η m due to the effect of the medication. However, the moment of treatment initiation is considered a probabilistic distribution along the infected class. Therefore, the maximum expected diffusion coefficient D max occurs at the initial stage of the disease, while its lowest expected value D min is reached when the patient is about to have AIDS symptoms.
Finally, the dynamics of the AIDS class population is given by the following expression,
where k A is the transfer rate constant from the infected class to the AIDS class. The death rate constant in A has been augmented by the parameter d to illustrate the mortality increases due to the disease. Note that only individuals in their last stage of infection develop AIDS.
Comparison to Existing Models
The diffusion model proposed in this work is discretized along the infection progression coordinate in order to compare it against existing models available in the literature. Existing HIV models describe the infected class by a sequence of discrete states, denoted by I i . The discretization of Eq. (2) in the η coordinate gives,
where the index i represents a generic disease progression stage inside the infected class. Notice that the boundary conditions at η = 0 and η = 1 are substituted in the expression above to account for the population flux from the susceptible class and to the developed AIDS class, respectively. The following discretization can be also considered in the case of a differentiable D(η),
Further discretization of either Eq.(4) or Eq.(5) provides a system of differential equations of the form,
where the index i varies from one (η = 0) to n (η = 1). The number of discretized stages in compartmental models (n) varies depending on the emphasis given by different authors to the infected class heterogeneity. Table 1 shows 
Eq.4 Eq.5 The comparison of Eq.(6) with a compartment model from the literature [Cai et al., 2009] demonstrates that the diffusion coefficient profile determines the transfer rate constants as well as the effect of the medical treatment. Figure 3 shows the profiles for S and I, where the distributed infected class has been discretized only into two compartments: I 0 and I 1 . Such profiles match those developed by previous researchers [Cai et al., 2009] for the asymptomatic and symptomatic compartments in which medication is delivered in a discrete fashion. The AIDS class has been omitted because it is decoupled from the other classes, and the model suggested for the AIDS class dynamics is equivalent to the one proposed in Eq.(3).
Equilibrium Profile
Equilibrium conditions are calculated by setting all time derivatives to zero,
where the subscript '*' indicates "at equilibrium conditions" . The boundary conditions for the diffusion term remain valid and are required to obtain the equilibrium profile. Integration of Eq.(7) along the infected class and substitution of the corresponding boundary conditions provides the following expression,
Note that β IÎ * S * > k I I * (1) in order to compensate for the natural mortality term, µÎ * . Fig. 4 . Equilibrium profiles for the infected class when treatment is expected to start at stages 0.3, 0.5 and 0.7 of the HIV disease progression.
The procedure to calculate the equilibrium profile requires the backward integration of Eq. (7) because the final conditions at η = 1 are known for a givenÎ * . The steps required to determine S * , I * (η) and A * are as follow:
• Assume an initial value forÎ * = 0 and calculate S * from the susceptible class equilibrium condition,
• Calculate I * (1) from the substitution of the boundary conditions for the integrated expression provided in Eq.(8),
• Using I * (1) and the boundary condition at η = 1,
integrate Eq. (7) backwards, i.e from η = 1 to η = 0.
• From the calculated profile I * (η) determineÎ * new .
• CompareÎ * new with the value assumed at the initial step of this procedure. If |Î * new −Î * | > tol then set I * =Î * new and proceed with a new iteration untilÎ * converges within the specified tolerance, tol.
The procedure described above provides a unique feasible equilibrium profile for a non-empty infected class,Î * = 0. Figure 4 illustrates a typical equilibrium profile for the infected class. The difference I * (0) − I * (1) is due to the death rate not associated with HIV for the expected period that an infected individual remains in this class. Based on recent publications [Schackman et al., 2006 ] such a period is approximately 32 years in the USA and depends on the amount of medication received by infected patients. However in this work, the time an infected individual spends in class I * varies based on when treatment is initiated.
The equilibrium profiles for treatment initiated at stages 0.3, 0.5 and 0.7 of the infection are shown in Figure 4 . Note that the main differentiator of these profiles is the number of infected individuals that are about to develop 
AIDS, i.e I * (1). The plots show that earlier treatment of infected patients along the infection progression path results in lower values of I * (1). This indicates that those individuals who received prompt medication have longer expectancy time in the infected class due to slow disease progression. Therefore, a significant number of individuals will never develop AIDS. Instead, they will die of natural causes not associated with HIV.
The mortality rate is identical for susceptible and infected individuals, and the results in Figure 4 indicate that the difference between early and late treatment could increase natural mortality in more than 50% of the infected individuals. In other words, an infected patient that starts treatment at stage 0.3 (30% of the disease progression in class I) has a 50% greater chances to never develop AIDS when compared to a patient that initiates treatment at stage 0.7 of the disease progression. Such an important conclusion can only be obtained when using the heterogenic population models proposed in this work.
HIV EPIDEMIC DYNAMICS
A community with no infected or AIDS class individuals has a susceptible population of S = K. A potential HIV epidemic is initiated when the first infected individual is placed at the infection initial stage, I(0, 0) = I 0 . The proliferation or eradication of the infection will depend on the reproductive ratio, 0 . However, such a ratio has been defined only for HIV multi-compartmental models [Hyman and Li, 2005] . Furthermore, the medication tends to reduce the infection progression defined in Section 2.2, as infected individuals can partially recover due to treatment. Table 2 provides the nominal values of the parameters used for the dynamic simulation. A sigmoid function profile is used to describe the effect of the medication on the infection progression diffusion coefficient, D(η),
The inflection point occurs at η m , which determines the most likely stage at which treatment starts along the infected class. Note that the effect of the medication reduces the diffusion coefficient from ≈ D max at η = 0 to ≈ D min at η = 1. Such a reduction significantly slows the infection progression rate, increasing the time that an individual stays in the infected class as well as mortality by natural causes not related to HIV. The parameter 'a' determines the dispersion of the distribution and is related to the probability of receiving treatment at the established infection stage, η m . Awareness of treatment importance and sufficient medical resources increase the value of a to a point where the diffusivity coefficient starts to approximate a step profile from D max to D min at η m . A typical response for the infected class due to the presence of infected individuals at the initial infection stage I 0 is given in Figure 5 (a). Notice the time required for the infection to progress and reach the last stage of the infected class, I 1 . The profiles for I 1 and I 0 reach a different steady state than those in the two compartment model shown in Figure 3 . The reason for this difference is that the distributed model proposed in this work describes the infected class using a significant number of stages instead of few compartments. HIV proliferates inside the infected class as the disease reaches the endemic equilibrium profile without complete eradication.
The disease transmission parameter β brings individuals from the susceptible to the infected class at a faster rate than the rate at which individuals develop AIDS. Either the reduction of the transmission parameter β or the fast progression and disappearance of infected individuals (large diffusivity) can completely eliminate the infected class. The former may require population awareness to prevent further spread of the disease; while the later option is not viable as medication is provided to increase the life expectancy of patients with HIV once an individual is known to be infected. Figure 5( b) illustrates the eradication of HIV by the sudden reduction of the disease transmission rate, β. In mathematical terms, the reduction in β results in a disease-free equilibrium profile (DFE) that attracts dynamic responses. Because the proposed model is non-linear, the region of attraction around the DFE depends on the proximity of the initial endemic equilibrium profile to the DFE.
The infected class averageÎ is considered a representative index to determine the effect of η m on the dynamic profile. Figure 6 (a) illustrates the effect of η m onÎ. As was the case in Section 4, early treatment reduces the expected average of the infected population along the average dynamic response profile. This figure also shows that the time at which the maximum is reached increases when the expected treatment time is decreased. However, in practice some medications might not be effective during early stages of the disease, which indicates the possibility of an optimum treatment stage for η m . Such an analysis will be conducted in future research work.
The AIDS class profile is separated from the rest of the responses due to its reduced population number when compared to the susceptible and infected class populations. The effect of η m on the AIDS class response is illustrated in Figure 6 (b). The number of AIDS cases at equilibrium significantly decreases from 0.17 for η m = 0.7 to 0.06 for η m = 0.3. Such a reduction indicates the importance of early treatment. The modeling approach proposed in this work demonstrates the effectiveness of describing the medication benefits by using representative parameters. Such parameters could be estimated using statistical data collected from a particular region of the world.
CONCLUSIONS
This work illustrates the use of a continuous-heterogeneous infected class to describe the dynamic propagation and treatment of HIV. The dynamic model makes use of a diffusion term that simulates the progression of the disease within the infected class. This progression is qualitatively determined by the continuous coordinate η. Susceptible individuals that acquire the disease enter the infected class at its initial stage η = 0, while those who are about to develop symptoms associated with AIDS leave the infected class at η = 1. Therefore, susceptible and AIDS class compartments serve as time varying boundary conditions for the diffusion term used inside the infected class.
This diffusion term accounts for the disease progression rate and depends on: the treatment effectiveness determined by the diffusion coefficient drop from D max to D min ; the most likely stage to initiate treatment , which is given by the diffusivity coefficient inflection location, η m ; and the homogeneity of population access to medical resources, represented by the dispersion parameter, a. Therefore, a significant number of empirical parameters required in a multi-compartment model can be specified by three parameters that define a diffusivity coefficient profile. This modeling approach permits one to define variants in HIV treatment without requiring a predefined number of infected class compartments. The numerical algorithm used to solve the PDE model implements an adjustable grid size to approximate the diffusion term without the need to define empirical transfer parameters between infection stages. This dynamic modeling approach used for HIV epidemics can be extended to other infectious diseases with only minor modifications.
